What is the price-to-earnings ratio of Wize Pharma?
The price-earnings ratio of Wize Pharma is currently 0.
Wize Pharma P/S 2024
Wize Pharma P/S
0
Ticker
WIZP
ISIN
US97751M2070
As of Dec 20, 2024, Wize Pharma's P/S ratio stood at 0, a 0% change from the 0 P/S ratio recorded in the previous year.
The Wize Pharma P/S history
Wize Pharma Aktienanalyse
What does Wize Pharma do?
Wize Pharma Inc. is a leading biopharmaceutical company specializing in the development and marketing of innovative products for the treatment of eye diseases. The company was founded in 1997 and is headquartered in Herzliya Pituach, Israel. It focuses on the research, development, manufacturing, and marketing of eye disease treatments. The company aims to become a leading brand in the field of eye health and offers high-quality services in eye care. Wize Pharma Inc. operates different divisions, with its main divisions being the development and marketing of eye therapeutics, including LO2A and LO2B. LO2A is an innovative therapy for dry eye, while LO2B is an intraoperative formulation used in glaucoma surgery. The company's products provide effective and sustainable solutions for the treatment of eye diseases. Wize Pharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/S Details
Decoding Wize Pharma's P/S Ratio
Wize Pharma's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.
Year-to-Year Comparison
Comparing Wize Pharma's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.
Impact on Investments
The P/S ratio is instrumental for investors evaluating Wize Pharma's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.
Interpreting P/S Ratio Fluctuations
Variations in Wize Pharma’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.
Frequently Asked Questions about Wize Pharma stock
How has the price-earnings ratio of Wize Pharma changed compared to last year?
The price-to-earnings ratio of Wize Pharma has increased by 0% fallen (meaning "decreased" or "dropped") compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Wize Pharma high compared to other companies?
Yes, the price-to-earnings ratio of Wize Pharma is high compared to other companies.
How does an increase in the price-earnings ratio of Wize Pharma affect the company?
An increase in the price-earnings ratio of Wize Pharma would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Wize Pharma affect the company?
A decrease in the price-earnings ratio of Wize Pharma would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Wize Pharma?
Some factors that influence the price-earnings ratio of Wize Pharma are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Wize Pharma pay?
Over the past 12 months, Wize Pharma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Wize Pharma is expected to pay a dividend of 0 USD.
What is the dividend yield of Wize Pharma?
The current dividend yield of Wize Pharma is .
When does Wize Pharma pay dividends?
Wize Pharma pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Wize Pharma?
Wize Pharma paid dividends every year for the past 0 years.
What is the dividend of Wize Pharma?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Wize Pharma located?
Wize Pharma is assigned to the 'Health' sector.
Wann musste ich die Aktien von Wize Pharma kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Wize Pharma from 12/20/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/20/2024.
When did Wize Pharma pay the last dividend?
The last dividend was paid out on 12/20/2024.
What was the dividend of Wize Pharma in the year 2023?
In the year 2023, Wize Pharma distributed 0 USD as dividends.
In which currency does Wize Pharma pay out the dividend?
The dividends of Wize Pharma are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Wize Pharma
Our stock analysis for Wize Pharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Wize Pharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
